Condition: Solid Tumors
Interventions: Drug: lenvatinib; Drug: pembrolizumab
Sponsor: Eisai Co., Ltd.
Not yet recruiting - verified December 2016
http://ift.tt/2iynFGf
http://ift.tt/2iqmefQ
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Employment is an important goal for persons who have a severe mental illness (SMI). The current literature finds some evidence fo...
-
International Journal of Environmental Research and Public Health IJERPH, Vol. 16, Pages 2240: Environmental Assessment and Evaluation of Ox...
-
Abstract Umbilical cord blood mesenchymal stem cells (UCB-MSCs) have been shown to be a source of stem cells for use in cellular therapies...
-
Abstract Purpose Women living with human immunodeficiency virus (WLWH) have a higher risk of cervical cancer than women without HIV. In ...
-
Mobile phones have come into daily life and are now one of the most frequently used devices for communication. The aim of this study was to ...
-
Publication date: 5 May 2017 Source: Polymer, Volume 116 Author(s): Ali Osman Konuray, Xavier Fernández-Francos, Xavier Ramis Epoxy-thiol...
-
Publication date: Available online 29 November 2016 Source: International Journal of Oral and Maxillofacial Surgery Author(s): N. Capan, S...
-
FDG PET and FES PET predict PFS on endocrine therapy : PURPOSE: 18F-fluoroestradiol (FES) positron emission tomography (PET) scans measure...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου